Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer by Thomas Franz Fassbender, Florian Schiller, Constantinos Zamboglou, Vanessa Drendel, Selina Kiefer, Cordula A. Jilg, Anca-Ligia Grosu, Michael Mix

Subjects: Get full text

The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2 by Yinwen Wang, Hongmei Yuan, Sufan Tang, Yang Liu, Ping Cai, Nan Liu, Yue Chen, Zhijun Zhou

Subjects: Get full text

Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of ⁶⁸Ga-PSMA and ⁶⁸Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patient... by Paola Mapelli, Samuele Ghezzo, Ana Maria Samanes Gajate, Erik Preza, Giorgio Brembilla, Vito Cucchiara, Naghia Ahmed, Carolina Bezzi, Luca Presotto, Valentino Bettinardi, Annarita Savi, Patrizia Magnani, Raffaele Menichini, Angela Coliva, Ilaria Neri, Ettore Di Gaeta, Luigi Gianolli, Massimo Freschi, Alberto Briganti, Francesco De Cobelli, Paola Scifo, Maria Picchio

Subjects: Get full text

The use of advanced imaging in guiding the further investigation and treatment of primary prostate cancer by Heying Duan, Andrei Iagaru

Subjects: Get full text